Inflammatory bowel disease is thought to arise from inappropriate inflammation to gut bacteria, yet mechanisms preventing these responses remain elusive. In this issue of Cell, Nanjundappa et al. report that Bacteroides share an epitope with a pancreas-specific peptide that induces protective CD8+ T cells, identifying molecular mimicry as a mechanism to enforce tolerance in the gut.
Crohn's Disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that occur due to a culmination of host genetic susceptibility, environment, and the microbiota. Some organisms within the microbiota are known to promote tolerant immune responses through the induction of T regulatory cells (Tregs), while others elicit antagonistic inflammatory subtypes, together balancing intestinal immune responses (Belkaid and Hand, 2014) . It is generally thought that inappropriate immune responses directed at commensal microbes may promote IBD. Education of the adaptive immune system by the microbiota has largely focused on bulk changes to CD4+ helper or CD8+ T cell subsets, with little known about the antigens that stimulate these cells. Many other autoimmune diseases, including type 1 diabetes (T1D), have been associated with perturbations to commensal microbes (Murri et al., 2013) , which result from both CD4+ and CD8+ T cell responses against pancreatic b cells. In this issue of Cell, Nanjundappa et al. (2017) illustrate that commensal Bacteroides spp. confer resistance to colitis by possessing integrases that contain a peptide motif similar to a pancreatic b cell peptide, driving immunomodulatory responses through a population of CD8+ T cells (Figure 1) .
Widely used as a model of T1D, nonobese diabetic (NOD) mice develop CD8+ T cells that respond to a peptide motif found in the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Studies over the last decade have indicated that high-avidity CD8+ T cell clones drive disease, while low-avidity subsets suppress disease by killing antigen-expressing dendritic cells (DCs). Thus, strength of T cell binding to antigen influences disease outcome in this model. Developmental studies identified that the frequency of these autoreactive T cells could not be explained by recognition of self-peptide IGRP alone, leading the authors to search the NCBI microbial database for sequences sharing homology to IGRP. Microbes have been hypothesized to undergo convergent evolution of peptide sequences to mimic host peptides, a process referred to as molecular mimicry (Elde and Malik, 2009) . While molecular mimicry is often considered in the context of pathogenic interactions, the ability of commensal microbes to mimic host peptides has not been thoroughly explored.
Human intestinal bacteria of the genus Bacteroides were determined to contain a transposable integrase with a peptide motif (referred to as BaclYL) that varies from IGRP by 2 amino-acid residues. This bacterial peptide was shown, in vitro, to be successfully presented by MHCI to IGRP-specific CD8+ T cells. While both low-(called 17.6) and high-(17.4) avidity TCR transgenic T cells could recognize the bacterial epitope, only the high-avidity T cells could produce IFN-g when exposed to high peptide concentration, a feature enhanced by microbial stimulation with LPS. The low-avidity TCR-expressing T cells could not be stimulated at any concentration of peptide. These data identified that commensal bacteria produce a motif that is a lowavidity target for autoreactive CD8+ T cells.
BaclYL elicited in vivo responses from multiple strains of mice, with nearly every IGRP-specific CD8+ T cell reacting against the bacterial BaclYL, indicating a high frequency of cross-reactivity between the host and microbial epitope. Extending these findings to humans, the authors analyzed peripheral blood mononuclear cells (PBMCs) from healthy controls and patients with either T1D or CD for cross-reactivity. Cells from each group of donors responded to BaclYL 36-44 in an MHCI-dependent manner, with highest reactivity in the cells that were isolated from healthy and T1D patients, indicating that cross-reactive cells are found in humans.
Since CD is thought to arise from immune responses against commensals, the authors hypothesized that maintenance of this cross-reactivity arose in an effort to preserve host-microbe homeostasis. To test this, they performed a series of elegant experiments during a model of experimental colitis. IGRP/ BaclYL-reactive cells were recruited to the intestine upon colitis induction, and TCR transgenic animals expressing the high avidity receptor (17.4) were protected from disease when compared to controls. The mechanism of preventing colitis was found to be similar to the suppression of diabetes in this model. To demonstrate this, the authors transferred CFSE-labeled DCs pulsed with the bacterial peptide, BaclYL, into TCR transgenic mice expressing either the high-avidity (17.4) or low-avidity (17.6) TCR. DCs loaded with bacterial peptide were killed only in animals expressing the high-avidity TCR receptor, indicating that resistance to colitis occurs by cytotoxic T cell responses against gut DCs presenting bacterial antigens.
The authors then sought to determine which Bacteroides strains express this mimetic peptide. Analysis of archived sequencing data indicated that B. vulgatus was the primary organism expressing this epitope but was also found in B. dorei. In contrast, the integrase sequence was missing in strains of B. distasonis, two B. fragilis strains, and B. thetaiotaomicron. Taking advantage of this, the authors monocolonized low-avidity TCR (colitis susceptible) transgenic germ-free mice with either integrase-expressing B. vulgatus or integrase-deficient B. distasonis and subsequently transferred T cells from the high-avidity (colitis-protected) TCR transgenic animal. Animals colonized with the integrase expressing B. vulgatus were protected from colitis, while animals colonized with the integrase deficient B. distasonis developed worsened disease. These results were not due to inherent differences between the two species, as B. thetaiotaomicron (that is normally integrase-negative) engineered to express the integrase could recapitulate the protection from colitis. Collectively, these results identify that commensal bacteria express mimetic peptides that can enforce host-microbe symbiosis within the gut (Figure 1) .
Induction of tolerant immunity against commensals has largely focused on Treg populations. Therefore, this work offers a novel mechanism for limiting inflammation toward resident bacteria through effector CD8+ cytotoxicity induced by molecular mimicry. Epitope sharing that provokes immunomodulatory responses could represent a novel strategy utilized in commensal relationships-one that could benefit the host through decreased inflammatory responses in the GI tract while stabilizing colonization of the microorganism. While the influence of epitope sharing on the ability of Bacteroides to colonize the GI tract was not addressed in this study, the loss of microbial diversity, as seen in western civilizations, could lead to forfeiture of immunomodulation through mimicry, increasing the risk of CD and UC. Furthermore, if immune regulation can occur through exposure to microbial mimics, these epitopes may illustrate an emerging treatment for IBD, similar to the use of glatiramer acetate (a mimic of the myelin basic peptide) as a treatment for multiple sclerosis (Lalive et al., 2011) .
This work indicates that autoreactive T cells can be subverted by gut bacteria to promote tolerance within the gut. Although not addressed in this study, diabetes is one of the top three comorbidities that a patient with UC will develop, and this system provides a unique opportunity to explore the relationship between these two diseases (Jurjus et al., 2016) . A cursory analysis demonstrated that the incidence of diabetes was not dependent on the expression of the bacterial integrase; however, the relationship should be further interrogated. Individuals with T1D have consistent changes to the composition of the microbiota when compared to healthy individuals, and this report identified that PBMCs from individuals with T1D were reactive to bacterial integrase, suggesting a role for mimicry in this setting.
Overall, this study demonstrates a novel system of immunomodulation through the ability of a commensal to mimic host epitopes that likely extends beyond colitis and diabetes. Indeed, over a decade ago, it was reported that gut bacteria express mimetic peptides associated with multiple sclerosis (Westall, 2006) . Investigating this process could lead to the identification of novel microbial products to modulate multiple autoimmune diseases. If microbial mimics are ever to be considered as a therapeutic agent, potential off-target effects would need to be thoroughly investigated. Regardless, this example of beneficial molecular mimicry strongly advances our understanding of host-commensal relationships.
